Company Filing History:

6 out of 940

Fujisawa Pharmaceutical Company, Ltd.

Years Active: 1991-2008

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7442715 - Thiazole derivatives (2008-10-28),

2. 7371842 - Polynucleotide encoding a 35 KDA protein thats binds to WF00144 (2008-05-13),

3. 7125901 - Thiazole derivatives (2006-10-24),

4. 6812235 - Beta-alanine derivatives and their use as receptor anatgonists (2004-11-02),

5. 6538007 - N-[(R)-1-[3-(4-piperidyl)propionyl]-3-piperidylcarbonyl]-2(S)-acetylamino-&bgr;-alanine trihydrate, compositions thereof, and methods for its use (2003-03-25),

6. 6384028 - N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein IIb/IIIa antagonists and fibrinogen-blood platelets binding inhibitors (2002-05-07),

7. 6380215 - Beta-alanine derivative and a process for the preparation thereof (2002-04-30),

8. 5622976 - Oxadiazole derivatives having acetylcholinesterase-inhibitory and (1997-04-22),

9. 5059608 - Bicyclic amine compound and a process for the preparation thereof (1991-10-22),

Title: Mitsuru Ohkubo: Innovator in Pharmaceutical Research

Introduction

Mitsuru Ohkubo is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical research, holding a total of 9 patents. His work primarily focuses on compounds that have therapeutic applications, particularly in the treatment of diabetes and related conditions.

Latest Patents

Ohkubo's latest patents include innovative compounds such as thiazole derivatives. These compounds are designed to act as vascular adhesion protein-1 (VAP-1) inhibitors, which are useful in preventing or treating diseases associated with VAP-1, especially macular edema. Another notable patent involves a polynucleotide encoding a 35 KDA protein that binds to WF00144. This invention aims to regulate sugar production and offers a method for screening compounds that can aid in diabetes treatment.

Career Highlights

Throughout his career, Mitsuru Ohkubo has worked with reputable companies in the pharmaceutical industry, including Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His expertise and innovative approach have led to advancements in drug development and therapeutic solutions.

Collaborations

Ohkubo has collaborated with notable colleagues such as Hisashi Takasugi and Atsushi Kuno, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Mitsuru Ohkubo's contributions to pharmaceutical research and his innovative patents highlight his role as a key figure in the development of new therapeutic solutions. His work continues to impact the field positively, paving the way for advancements in diabetes treatment and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.